Your browser doesn't support javascript.
loading
First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, nf-κΒ and p70s6k, in patients with advanced solid tumors.
Hong, D S; Henary, H; Falchook, G S; Naing, A; Fu, S; Moulder, S; Wheler, J J; Tsimberidou, A; Durand, J B; Khan, R; Yang, P; Johansen, M; Newman, R A; Kurzrock, R.
Afiliação
  • Hong DS; Department of Investigational Cancer Therapeutics (Phase I Program), University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 455, Houston, TX, 77030, USA, dshong@mdanderson.org.
Invest New Drugs ; 32(6): 1204-12, 2014 Dec.
Article em En | MEDLINE | ID: mdl-24919855

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Extratos Vegetais / Nerium / Neoplasias / Antineoplásicos Fitogênicos Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Extratos Vegetais / Nerium / Neoplasias / Antineoplásicos Fitogênicos Idioma: En Ano de publicação: 2014 Tipo de documento: Article